Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC
{{output}}
PURPOSE RETINOBLASTOMA L: (RB1) mutations frequently emerge as late subclonal events in advanced prostate cancer (PCa), driving inevitable recurrence and therapy resistance. Therapy-induced senescence (TIS) could promote metastasis at a late stage. However, th... ...
